CBUS Cibus US LLC
Price Chart
Executive Summary
Cibus US LLC (CBUS) announced the pricing of a public offering of 6,976,744 shares at $2.15 per share, raising approximately $15 million in gross proceeds, with a potential increase to $17.2 million if the underwriter's over-allotment option is exercised. The company plans to use the net proceeds for working capital and to fund development of its weed management traits in rice.
Key Financial Metrics
Actionable Insight
Traders should monitor for potential short-term downward pressure on the stock due to share dilution, though the use of proceeds for R&D may support long-term value if development milestones are achieved.
Key Facts
- Cibus is offering 6,976,744 shares of Class A Common Stock at $2.15 per share.
- Gross proceeds are expected to be $15 million, or $17.2 million if the over-allotment option is fully exercised.
- The offering is expected to close on March 27, 2026, subject to customary conditions.
- Proceeds will be used for working capital and to fund development of weed management traits in rice.
- BTIG, LLC is the sole underwriter; the offering is made under an existing shelf registration.
Financial Impact
$15 million in gross proceeds ($17.2 million if over-allotment is exercised), leading to moderate dilution.
Risk Factors
- Dilution from new share issuance could pressure the stock price.
- Proceeds are for general corporate purposes and R&D, which may not yield near-term commercial returns.
- Market conditions could affect the final execution if the over-allotment is not exercised.
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3262836 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
2d ago
|
Institutional Cluster
| $1.21 awaiting T+5 | awaiting T+5 | — | $1.23 (+2.07%) |
|
Jun 9, 2026
4d ago
|
8-K
| $1.22 awaiting T+5 | awaiting T+5 | — | $1.23 (+1.23%) |
|
Jun 8, 2026
4d ago
|
Press Release
| $1.22 awaiting T+5 | awaiting T+5 | — | $1.23 (+1.23%) |
|
May 26, 2026
18d ago
|
EFFECT
| $1.43 $1.39 | ▲ +2.80% | ▲ +4.01% | $1.23 (+13.99%) |
|
May 14, 2026
29d ago
|
8-K
| $1.31 $1.38 | ▲ +5.34% | ▲ +4.38% | $1.23 (−6.11%) |
|
May 4, 2026
5w ago
|
Press Release
| $1.49 $1.38 | ▼ −7.38% | ▼ −10.32% | $1.23 (−17.45%) |
|
Apr 20, 2026
7w ago
|
DEFA14A
| $1.49 $1.42 | ▼ −4.70% | ▼ −5.78% | $1.23 (−17.45%) |
|
Mar 26, 2026
11w ago
|
424B5
| $1.88 $1.91 | ▼ −1.60% | ▲ +2.27% | $1.23 (+34.57%) |
|
Mar 26, 2026
11w ago
|
Press Release
| $2.13 $1.98 | ▼ −7.04% | ▼ −8.68% | $1.23 (−42.25%) |
|
Mar 25, 2026
11w ago
|
Press Release
| $2.13 $1.98 | ▼ −7.04% | ▼ −8.68% | $1.23 (−42.25%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access